Dejan Micic to Female
This is a "connection" page, showing publications Dejan Micic has written about Female.
Connection Strength
0.483
-
Predictive Model for Positive Video Capsule Endoscopy in Iron Deficiency Anemia. Dig Dis Sci. 2023 07; 68(7):3083-3091.
Score: 0.044
-
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis. Inflamm Bowel Dis. 2021 10 18; 27(10):1620-1625.
Score: 0.040
-
Impact of Early Video Capsule Endoscopy on Hospitalization and Post-hospitalization Outcomes: A Propensity Score-Matching Analysis. Dig Dis Sci. 2022 08; 67(8):3584-3591.
Score: 0.040
-
Hiding in the Water. N Engl J Med. 2020 May 07; 382(19):1844-1849.
Score: 0.036
-
Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy. PLoS One. 2019; 14(2):e0212509.
Score: 0.033
-
Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study. Dig Dis Sci. 2018 04; 63(4):1016-1024.
Score: 0.031
-
Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS One. 2017; 12(8):e0182900.
Score: 0.030
-
Mediastinal granuloma: a rare cause of dysphagia. BMJ Case Rep. 2016 Jun 14; 2016.
Score: 0.028
-
Older Age at First Screening Colonoscopy is Associated With an Increased Risk of Colorectal Adenomas and Cancer. J Clin Gastroenterol. 2023 09 01; 57(8):804-809.
Score: 0.011
-
Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes. Clin Gastroenterol Hepatol. 2021 11; 19(11):2444-2446.e2.
Score: 0.009
-
TGR5 signaling mitigates parenteral nutrition-associated liver disease. Am J Physiol Gastrointest Liver Physiol. 2020 02 01; 318(2):G322-G335.
Score: 0.009
-
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission. J Gastroenterol Hepatol. 2019 Dec; 34(12):2090-2095.
Score: 0.009
-
Risk Factors for 30-day Hospital Readmission for Diverticular Hemorrhage. J Clin Gastroenterol. 2019 04; 53(4):e133-e141.
Score: 0.008
-
Risk of Colorectal Cancer in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol. 2018 10; 52(9):796-804.
Score: 0.008
-
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2019 02; 17(3):486-493.
Score: 0.008
-
Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018 06; 19(6):758-767.
Score: 0.008
-
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860.
Score: 0.008
-
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Aliment Pharmacol Ther. 2018 Mar; 47(6):753-762.
Score: 0.008
-
Meta-Analysis of the Risk of Immune-Related Adverse Events With Anticytotoxic T-Lymphocyte-Associated Antigen 4 and Antiprogrammed Death 1 Therapies. Clin Pharmacol Ther. 2018 02; 103(2):318-331.
Score: 0.008
-
Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-a agent (infliximab), in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 04; 45(8):1043-1057.
Score: 0.007
-
Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-a use in females with immune mediated diseases; a systematic review and meta-analysis. J Autoimmun. 2017 01; 76:38-52.
Score: 0.007
-
Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis. 2016 Dec; 10(12):1385-1394.
Score: 0.007
-
Primary Care Evaluation and Management of Gastroenterologic Issues in Women. Obstet Gynecol Clin North Am. 2016 Jun; 43(2):347-66.
Score: 0.007
-
The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.
Score: 0.007
-
Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015 Jul 15; 61(2):233-41.
Score: 0.006
-
Patchy colitis and interstitial lung disease. Gastroenterology. 2015 Jan; 148(1):26-7.
Score: 0.006
-
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease. J Crohns Colitis. 2014 Nov; 8(11):1539-47.
Score: 0.006
-
Challenges in the diagnosis of Clostridium difficile infection. Gastroenterology. 2014 Jun; 146(7):1820-2.
Score: 0.006
-
The systemic inflammatory response to Clostridium difficile infection. PLoS One. 2014; 9(3):e92578.
Score: 0.006
-
Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS One. 2014; 9(2):e89332.
Score: 0.006
-
Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults. J Am Geriatr Soc. 2013 Oct; 61(10):1738-42.
Score: 0.006
-
Understanding increased mortality in Clostridium difficile-infected older adults. Clin Infect Dis. 2013 Aug; 57(4):625-6.
Score: 0.006
-
Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One. 2013; 8(3):e58265.
Score: 0.006
-
Reply to Walker et al. Clin Infect Dis. 2013 Jun; 56(12):1846-7.
Score: 0.006
-
Reply to McDonald. Clin Infect Dis. 2013 Mar; 56(6):907-8.
Score: 0.005
-
Clostridium difficile ribotype does not predict severe infection. Clin Infect Dis. 2012 Dec; 55(12):1661-8.
Score: 0.005
-
[Diverticulosis of the digestive tract in our patients over a 10-year period]. Zb Vojnomed Akad. 1981; 23:42-5.
Score: 0.002